MARKET

AZTA

AZTA

Azenta Inc
NASDAQ
63.37
-0.01
-0.02%
After Hours: 63.37 0 0.00% 16:20 02/23 EST
OPEN
63.62
PREV CLOSE
63.38
HIGH
64.06
LOW
62.91
VOLUME
508.39K
TURNOVER
0
52 WEEK HIGH
69.16
52 WEEK LOW
36.01
MARKET CAP
3.53B
P/E (TTM)
-201.1108
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AZTA last week (0212-0216)?
Weekly Report · 02/19 09:33
Analysts Anticipate IYH Will Reach $330
NASDAQ · 02/14 11:54
Weekly Report: what happened at AZTA last week (0205-0209)?
Weekly Report · 02/12 09:30
Stephens & Co. Reiterates Equal-Weight on Azenta, Maintains $70 Price Target
Benzinga · 02/08 17:41
Analysts Offer Insights on Healthcare Companies: Azenta (AZTA), Neurocrine (NBIX) and McKesson (MCK)
Analysts have reiterated Buy ratings on Azenta (AZTA), Neurocrine (NBIX) and McKesson (MCK) Needham analyst David Saxon reiterated a Buy rating on the Healthcare sector with a price target of $75.00 for Azenta. In a report released yesterday, Bank of America Securities also reiterated a buy rating on McKesson.
TipRanks · 02/08 10:30
Needham Maintains Buy on Azenta, Lowers Price Target to $75
Benzinga · 02/08 10:17
Strong Buy Rating for Azenta, Inc. Amid Growth and Strategic Initiatives
TipRanks · 02/08 04:15
Azenta Reiterates FY24 Guidance
The company is reiterating revenue and earnings guidance for fiscal year 2024. Total revenue is expected to be in the range of $696 to $718 million. The company expects organic revenue growth of 5% to 8% for the same period. The stock is up 2% today.
Benzinga · 02/07 22:29
More
About AZTA
Azenta, Inc. is a provider of life science sample exploration and management solutions for the life sciences market. The Company operates through two segments. The Life Sciences Products segment provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments. The segment’s product offerings include automated cold storage systems, cryogenic storage systems, consumables and instruments and the associated services business for these products. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, as well as sample-based laboratory services to advance scientific research and support drug development. The segment’s service offerings include sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services.

Webull offers Azenta Inc stock information, including NASDAQ: AZTA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZTA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZTA stock methods without spending real money on the virtual paper trading platform.